Mechanism of autophagy activation in exercise-induced anti-diabetic benefits
自噬激活在运动引起的抗糖尿病益处中的机制
基本信息
- 批准号:10522769
- 负责人:
- 金额:$ 46.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-12 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAcuteAddressAffectAntidiabetic DrugsAutomobile DrivingAutophagocytosisAutophagosomeBindingBiochemicalBiologicalBiologyBlood CirculationCellsCellular biologyCommunicationComplexContractsCultured CellsDataDegradation PathwayDiseaseExerciseExtracellular Matrix ProteinsFastingFibronectin ReceptorsFibronectinsGeneticGlycoproteinsHigh Fat DietImpairmentIntegrin Signaling PathwayIntegrin alpha5beta1IntegrinsKnock-inKnock-in MouseLiverLysosomesMAPK8 geneMediatingMetabolicMetabolismModelingMusMuscleMuscle CellsMuscle ContractionMuscle FibersMyoblastsNon-Insulin-Dependent Diabetes MellitusPathway interactionsPhysical ExercisePhysiologicalPlayPreventionProteinsProteomicsRegulationRestRisk FactorsRoleSerumSignal PathwaySignaling MoleculeSkeletal MuscleStressStructureTherapeutic InterventionTissuesUndifferentiatedWild Type Mousebasefeedingglucose metabolismglucose toleranceinsulin sensitizing drugsknock-downmouse modelmutantpreventreceptorstressortherapeutic developmenttumorigenesis
项目摘要
Modified Project Summary / Abstract Section
This is a renewal application for R01 DK113170 to investigate the role and mechanism of autophagy activation in the regulation of exercise-induced metabolic benefits against type 2 diabetes (T2D). T2D is a sedentarism-associated disease affecting glucose metabolism and a risk factor for other disorders. Physical exercise has been widely recognized to exert beneficial effects against T2D. However, the mechanisms by which exercise elicits systemic metabolic benefits are unclear, which limits the development of therapeutic interventions. Autophagy is an essential intracellular degradation pathway, in which damaged or unnecessary cargos are transported to and broken down in lysosomes. It occurs at a low basal level under normal conditions, and can be induced by stressors such as fasting. We found that exercise is a potent inducer of autophagy, not only in contracting muscle tissues but also systemically in non-contractile tissues such as the liver. The mechanism and metabolic importance of autophagy activation by exercise in non-contractile tissues have never been addressed. Our preliminary data reveal that systemic autophagy activation may be mediated by exercise-induced circulating factors. By proteomic studies we discovered that fibronectin (Fn1), generally considered as an extracellular matrix protein under normal (resting) conditions, is significantly increased in the circulation after acute exercise. Importantly, muscle-specific depletion of fibronectin (FN1[delta]muscle mice) abolishes exercise-induced circulating fibronectin levels, autophagy activation in the liver, and systemic insulin sensitization, suggesting that muscle-secreted fibronectin is an essential regulator of exercise-induced systemic autophagy and metabolic benefits. In addition, knockdown of the fibronectin receptor, α5β1 integrin, abolishes the ability of exercised mouse serum in activating autophagy in cultured cells, further supporting the key role of the fibronectin-α5β1 integrin pathway in exercise-induced autophagy. Based on these data, we propose our overall hypothesis that autophagy activation in non-contractile tissues drives exercise-induced metabolic benefits against T2D, through a fibronectin-α5β1 integrin-IKK-JNK1 pathway. Using a combination of genetic, metabolic, biochemical, and cell biology approaches, we propose two aims: Aim 1 is to determine whether exercise activates autophagy systemically in non-contractile tissues via the fibronectin-α5β1 integrin-IKK-JNK1 pathway; and Aim 2 is to determine whether autophagy activation by the fibronectin-α5β1 integrin-JNK pathway in non-contractile tissues mediates exercise-induced metabolic benefits against T2D. Overall, our studies will establish the physiological importance of exercise-activated autophagy in non-contractile tissues in the prevention of T2D, and will demonstrate the previously uncharacterized function and mechanism of the fibronectin-integrin signaling pathway in regulating muscle-liver communication and whole-body metabolism.
修改项目摘要/摘要部分
这是R 01 DK 113170的更新申请,旨在研究自噬激活在调节运动诱导的代谢益处对抗2型糖尿病(T2 D)中的作用和机制。T2 D是一种影响葡萄糖代谢的久坐症相关疾病,也是其他疾病的风险因素。体育锻炼已被广泛认为对T2 D发挥有益作用。然而,运动增强全身代谢益处的机制尚不清楚,这限制了治疗干预的发展。自噬是细胞内一种重要的降解途径,将损伤的或不必要的物质转运到溶酶体中并在其中分解。在正常情况下,它发生在低基础水平,并且可以由禁食等压力源诱发。我们发现,运动是一种有效的自噬诱导剂,不仅在收缩的肌肉组织中,而且在非收缩组织如肝脏中也是如此。运动对非收缩性组织中自噬激活的机制和代谢重要性从未得到解决。我们的初步数据显示,系统性自噬激活可能是由运动诱导的循环因子介导的。通过蛋白质组学研究,我们发现纤连蛋白(Fn 1),通常被认为是在正常(休息)条件下的细胞外基质蛋白,在急性运动后的循环中显着增加。重要的是,肌肉特异性纤连蛋白耗竭(FN 1 [delta]肌肉小鼠)消除了运动诱导的循环纤连蛋白水平、肝脏中的自噬激活和全身胰岛素敏化,表明肌肉分泌的纤连蛋白是运动诱导的全身自噬和代谢益处的重要调节剂。此外,纤连蛋白受体α5β1整联蛋白的敲低消除了运动小鼠血清激活培养细胞中自噬的能力,进一步支持了纤连蛋白-α5β1整联蛋白途径在运动诱导的自噬中的关键作用。基于这些数据,我们提出了我们的总体假设,即非收缩组织中的自噬激活通过纤连蛋白-α5β1整合素-IKK-JNK 1途径驱动运动诱导的代谢益处对抗T2 D。使用遗传、代谢、生物化学和细胞生物学方法的组合,我们提出了两个目的:目的1是确定运动是否通过纤连蛋白-α5β1整联蛋白-IKK-JNK 1途径在非收缩性组织中全身性激活自噬;目的2是确定在非收缩性组织中通过纤连蛋白-α5β1整联蛋白-JNK途径的自噬激活是否介导运动诱导的针对T2 D的代谢益处。总的来说,我们的研究将建立运动激活的自噬在非收缩组织中预防T2 D的生理重要性,并将证明纤连蛋白-整合素信号通路在调节肌肉-肝脏通讯和全身代谢中的先前未表征的功能和机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Congcong He其他文献
Congcong He的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Congcong He', 18)}}的其他基金
Autophagy-facilitated secretion in metabolic maintenance
自噬促进代谢维持中的分泌
- 批准号:
10367132 - 财政年份:2021
- 资助金额:
$ 46.15万 - 项目类别:
Autophagy-facilitated secretion in metabolic maintenance
自噬促进代谢维持中的分泌
- 批准号:
10490364 - 财政年份:2021
- 资助金额:
$ 46.15万 - 项目类别:
Autophagy-facilitated secretion in metabolic maintenance
自噬促进代谢维持中的分泌
- 批准号:
10665778 - 财政年份:2021
- 资助金额:
$ 46.15万 - 项目类别:
Mechanism of autophagy activation in exercise-induced anti-diabetic benefits
自噬激活在运动引起的抗糖尿病益处中的机制
- 批准号:
10704114 - 财政年份:2017
- 资助金额:
$ 46.15万 - 项目类别:
A novel autophagy gene beclin 2 in the prevention of type 2 diabetes and obesity
新型自噬基因 beclin 2 预防 2 型糖尿病和肥胖
- 批准号:
8774357 - 财政年份:2014
- 资助金额:
$ 46.15万 - 项目类别:
A novel autophagy gene beclin 2 in the prevention of type 2 diabetes and obesity
新型自噬基因 beclin 2 预防 2 型糖尿病和肥胖
- 批准号:
8989093 - 财政年份:2014
- 资助金额:
$ 46.15万 - 项目类别:
A novel autophagy gene beclin 2 in the prevention of type 2 diabetes and obesity
新型自噬基因 beclin 2 预防 2 型糖尿病和肥胖
- 批准号:
8538967 - 财政年份:2012
- 资助金额:
$ 46.15万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 46.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 46.15万 - 项目类别:
Operating Grants














{{item.name}}会员




